Indication

Treatment in adults of other chronic fibrosing interstitial lung diseases with a progressive phenotype.

Medicine details

Medicine name:
nintedanib (Ofev)
SMC ID:
SMC2331
Pharmaceutical company
Boehringer Ingelheim Ltd
BNF chapter
Respiratory system
Submission type
Full
Publication due date:
14 June 2021
SMC meeting date:
04 May 2021
Patient group submission deadline:
01 March 2021